Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Medtronic ( (MDT) ) is now available.
On November 1, 2025, Medtronic announced the retirement of Gregory L. Smith, Executive Vice President of Enterprise Operations, effective December 2, 2025. His departure will involve the acceleration of unvested stock options and continued vesting of restricted stock units and performance stock units, as per the company’s equity compensation policies.
The most recent analyst rating on (MDT) stock is a Buy with a $101.00 price target. To see the full list of analyst forecasts on Medtronic stock, see the MDT Stock Forecast page.
Spark’s Take on MDT Stock
According to Spark, TipRanks’ AI Analyst, MDT is a Outperform.
Medtronic’s strong financial performance and positive earnings call sentiment are key strengths, supporting a robust growth outlook. However, technical analysis indicates bearish momentum, and the high P/E ratio suggests potential overvaluation. These factors collectively result in a moderate overall stock score.
To see Spark’s full report on MDT stock, click here.
More about Medtronic
Medtronic plc operates in the medical technology industry, providing a wide range of products and services including advanced medical devices and therapies. The company focuses on improving healthcare outcomes and enhancing patient care globally.
Average Trading Volume: 6,999,211
Technical Sentiment Signal: Buy
Current Market Cap: $116.3B
For an in-depth examination of MDT stock, go to TipRanks’ Overview page.